gp 1-515 has been researched along with Anasarca in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellino, AJ; DaRe, JS; Erion, MD; Kopcho, JJ; Ramirez-Weinhouse, M; Rosengren, S; Ugarkar, BG | 1 |
| Bong, GW; Firestein, GS; Rosengren, S | 1 |
2 other study(ies) available for gp 1-515 and Anasarca
| Article | Year |
|---|---|
Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Leukocyte Count; Neutrophils; Nucleosides; Phosphorylation; Purinergic P1 Receptor Antagonists; Rats; Skin; Structure-Activity Relationship; Theobromine | 2003 |
Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage.
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Carrageenan; Chemotaxis, Leukocyte; Edema; Hemodynamics; Male; Neutrophils; Rats; Rats, Inbred Strains; Ribonucleosides; Skin Diseases | 1995 |